National Health Act 1953 Determination under subsections 85A(1) and (2) and 88(1C) Prescription of pharmaceutical benefits by authorised optometrists (No. PB 78 of 2008) (Cth)

Determination — Prescription of pharmaceutical benefits by authorised Optometrists (PB 78 of 2008)

as amended

made under subsections 85A(1) and (2) and 88(1C)  of the

National Health Act 1953

This compilation was prepared on 1 November 2008

taking into account amendments up to PB 100 of 2008

Prepared by the Office of Legislative Drafting and Publishing,
Attorney-General’s Department, Canberra

Determination – Prescription of pharmaceutical benefits by authorized Optometrists (PB 78 of 2008)

1          Commencement [see Note 1]

This instrument commences on 1 August 2008.

2          Repeal

Instrument number PB 10 of 2008 is repealed.

3          Definition

In this instrument:

Act means the National Health Act 1953.

4          Form allowable

For subsection 85A(1) of the Act, the form of a pharmaceutical benefit mentioned in an item of Schedule 1 that is allowable for prescription by an authorised optometrist is the form mentioned in the description of the pharmaceutical benefit in the item.

Note   More than 1 form may have been determined for a pharmaceutical benefit , in which case each form is allowable for prescription: see Acts Interpretation Act 1901, para 23 (b).

5          Maximum quantity or number of units

(1)        For paragraph 85A (2) (a) of the Act, the maximum quantity or number of units of a pharmaceutical benefit mentioned in an item of Schedule 1 that an authorised optometrist may, in 1 prescription, direct to be supplied on any 1  occasion, either for all purposes or for a particular purpose (if any) mentioned in the item, is the quantity or number of units mentioned in the item.

(2)        For this section, the maximum quantity of a pharmaceutical benefit mentioned in an item in Schedule 1 is in the form mentioned in the description of the  pharmaceutical benefit in the item.

Note   A pharmaceutical benefit may or may not have a pharmaceutical item. The description of a pharmaceutical benefit in an individual item of Schedule 1 makes it clear whether the item relates to a pharmaceutical benefit that has a pharmaceutical item or not.

6          Maximum number of repeats

For paragraph 85A (2) (b) of the Act, the maximum number of occasions for which an authorised optometrist may, in 1 prescription, direct that the supply of a pharmaceutical benefit mentioned in an item of Schedule 1 be repeated, either for all purposes or for a particular purpose (if any) mentioned in the item, is the number mentioned in the item.

7          Manner of administration

For paragraph 85A (2) (c) of the Act, the manner of administration of a pharmaceutical benefit mentioned in an item of Schedule 1 that an authorised optometrist may, in a prescription, direct to be used is the manner of administration mentioned in the description of the pharmaceutical benefit in the item.

8          Pharmaceutical benefits that may be prescribed by authorised optometrists

For subsection 88 (1C) of the Act, an authorised optometrist is authorised to write a prescription for the supply of a pharmaceutical benefit that is mentioned in Schedule 1.

9          Particular purpose of supply of a pharmaceutical benefit

For sections 4 and 5, if there are any particular purposes for which the supply of a pharmaceutical benefit may be directed:

(a)        those purposes are identified by the purpose code in the item of Schedule 1 dealing with the particular pharmaceutical benefit; and

(b)        the purpose that the purpose code stands for is set out in the lower part of the item.

SCHEDULE 1   MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS BY AUTHORISED OPTOMETRISTS (sections 3 to 7)
Pharmaceutical Benefit				Purposes of Supply
Listed drug	Form	Manner of administration	Brand	For all purposes (other than a particular purpose)		For particular purposes (purpose code followed by quantity or number)
				Maximum quantity or number	Maximum repeats	Maximum quantity or number	Maximum repeats
Aciclovir	Eye ointment 30 mg per g, 4.5 g	Application to the eye	Zovirax	1	..
Carbomer 974	Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30	Application to the eye	Poly Gel	3	5
Carbomer 980	Ocular lubricating gel 2 mg per g, 10 g	Application to the eye	GelTears PAA Viscotears Liquid Gel	1	5
Eye drops 2 mg per g, single dose units 0.6 mL, 30	Application to the eye	Viscotears	3	5
Carmellose	Eye drops containing carmellose sodium 5 mg per mL, 15 mL	Application to the eye	Refresh Tears Plus	1	5
Eye drops containing carmellose sodium 10 mg per mL, 15 mL	Application to the eye	Refresh Liquigel	1	5
Eye drops containing carmellose sodium 2.5 mg per mL, single dose units 0.6 mL, 24	Application to the eye	TheraTears	4	5
Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30	Application to the eye	Cellufresh	3	5
Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30	Application to the eye	Celluvisc	3	5
Ocular lubricating gel containing carmellose sodium 10 mg per mL, single dose units 0.6 mL, 28	Application to the eye	TheraTears	3	5
Chloramphenicol	Eye drops 5 mg per mL, 10 mL	Application to the eye	Chloromycetin Chlorsig	1	2
Eye ointment 10 mg per g, 4 g	Application to the eye	Chloromycetin Chlorsig	1	..
Cromoglycic Acid	Eye drops containing sodium cromoglycate 20 mg per mL, 10 mL	Application to the eye	Cromolux Opticrom	1	5
Fluorometholone	Eye drops 1 mg per mL, 5 mL	Application to the eye	Flucon FML Liquifilm	1	..
Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL	Application to the eye	Flarex	1	..
SCHEDULE 1   MATTERS RELATING TO THE WRITING OF PRESCRIPTIONS FOR PHARMACEUTICAL BENEFITS BY AUTHORISED OPTOMETRISTS — continued (sections 3 to 7)
Pharmaceutical Benefit				Purposes of Supply
Listed drug	Form	Manner of administration	Brand	For all purposes (other than a particular purpose)		For particular purposes (purpose code followed by quantity or number)
				Maximum quantity or number	Maximum repeats	Maximum quantity or number	Maximum repeats
Flurbiprofen	Eye drops containing flurbiprofen sodium 300 micrograms per mL, single dose units 0.4 mL, 5	Application to the eye	Ocufen	1	..
Hydrocortisone	Eye ointment containing hydrocortisone acetate 5 mg per g, 5 g	Application to the eye	Hycor	1	..
Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g	Application to the eye	Hycor	1	..
Hypromellose	Eye drops 3 mg per mL, 15 mL	Application to the eye	Genteal In a Wink Moisturising	1	5
Eye drops 5 mg per mL, 15 mL	Application to the eye	Methopt	1	5
Hypromellose with Carbomer 980	Ocular lubricating gel 3 mg-2 mg per g, 10 g	Application to the eye	Genteal gel HPMC PAA	1	5
Hypromellose with Dextran	Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL	Application to the eye	Poly-Tears Tears Naturale	1	5
Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28	Application to the eye	Bion Tears	3	5
Paraffin	Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g	Application to the eye	Duratears Poly Visc	2	5
Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g	Application to the eye	Ircal Lacri-Lube Poly Visc	1	5
Polyethylene Glycol 400 with Propylene Glycol	Eye drops 4 mg-3 mg per mL, 15 mL	Application to the eye	Systane	1	5
Eye drops 4 mg-3 mg per mL, single dose units 0.8 mL, 28	Application to the eye	Systane	2	5
Polyvinyl Alcohol	Eye drops 14 mg per mL, 15 mL	Application to the eye	Liquifilm Tears PVA Tears	1	5
Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)	Application to the eye	Vistil	1	5
Eye drops 30 mg per mL, 15 mL	Application to the eye	Liquifilm Forte PVA Forte	1	5
Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)	Application to the eye	Vistil Forte	1	5
Sulfacetamide	Eye drops containing sulfacetamide sodium 100 mg per mL, 15 mL	Application to the eye	Bleph 10	1	2
Tamarindus indica seed polysaccharide	Eye drops 10 mg per mL, 0.5 mL, 20	Application to the eye	Visine Professional	3	5

Notes to the Determination — Prescription of pharmaceutical benefits by authorized optometrists (PB 78 of 2008)

Note 1

The Determination — Prescription of pharmaceutical benefits by authorized optometrists (PB 78 of 2008) (in force under sections 85A(1) and (2) and 88(1C) of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.

Table of Instruments

Title	Date of FRLI Registration	Date of commencement	Application, saving or transitional provisions
PB 78 of 2008	24 July 2008 (see F2008L02617)
PB 100 of 2008	17 Oct 2008 (see F2008L03759)	1 Nov 2008	—

Table of Amendments

ad. = added or inserted      am. = amended      rep. = repealed      rs. = repealed and substituted
Provision affected	How affected
Schedule 1
Schedule 1..........................................	am. PB 100 of 2008